Țară: Germania
Limbă: engleză
Sursă: HMA (Heads of Medicines Agencies)
newcastle disease virus 6 EID50
Lohmann Animal Health & Co.
QI01AD06
Oral lyophilisate
Newcastle disease virus / paramyxovirus vaccine
Chicken Young
2011-05-06
AviPro ND C131, PIL_cleared 1 PACKAGE LEAFLET DIRECTIONS FOR USE AviPro ND C131 Lyophilisate for suspenion 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH RELEASE, IF DIFFERENT Lohmann Animal Health GmbH, Heinz-Lohmann-Straße 4, D-27472 Cuxhaven, Germany 2. NAME OF THE VETERINARY MEDICINAL PRODUCT AviPro ® ND C131 Lyophilisate for suspension 3. STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) 1 dose contains: Active substance: min. 10 6.0 and max. 10 7.2 EID 50 Newcastle Disease Virus, live, strain clone 13-1 Appearance: off-white *EID 50 = 50%-embryo infectious dose: the virus titre causing infection in 50% of the embryos inoculated with the virus. 4. INDICATION(S) Active immunisation of chicken against Newcastle disease to reduce clinical signs and mortality. In broilers Onset of immunity: 3 weeks after vaccination (7 days in seronegative chickens) Duration of immunity: 4 weeks after vaccination (based on serological levels) In layers/breeders Onset of immunity: 3 weeks after the first vaccination Duration of immunity: 9 weeks after the application of the complete vaccine scheme performed accordingly with the recommended scheme (based on serological levels) 5. CONTRAINDICATIONS Do not use in unhealthy birds. See also section 9. 6. ADVERSE REACTIONS 6-15 days after vaccination slight reactions of the respiratory tract (coughing or sneezing) may be observed due to replication of the virus in the target cells, but this does not influence the performance of the birds. At least 15 days after vaccination, specific respiratory signs were seen after appli Citiți documentul complet
AviPro ND C131, SPC_cleared 1 _[VERSION 7.3.1, 11/2010] _ 1. NAME OF THE VETERINARY MEDICINAL PRODUCT AviPro ND C131 Lyophilisate for suspension 2. QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE SUBSTANCE : 1 dose contains Newcastle Disease Virus, live, strain clone 13-1 min. 10 6.0 and max. 10 7.2 EID 50 /dose *EID 50 = 50%-embryo infectious dose: the virus titre causing infection in 50% of the embryos inoculated with the virus. EXCIPIENTS: For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Lyophilisate for suspension Appearance: off-white pellet 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Chicken (from 14 days old) 4.2 INDICATIONS FOR USE,SPECIFYING THE TARGET SPECIES Active immunisation of chickens against Newcastle disease to reduce clinical signs and morta lity. In broilers Onset of immunity: 3 weeks after vaccination (7 days in seronegative chickens) Duration of immunity: 4 weeks after vaccination (based on serological levels) In layers/breeders Onset of immunity: 3 weeks after the first vaccination Duration of immunity: 9 weeks after the application of the complete vaccine scheme performed accordingly with the recommended scheme described under point 4.9 (based on serological levels) 4.3 CONTRAINDICATIONS Do not use in unhealthy birds. See also section 4.4 and 4.7 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES Do not use for breeders in lay. AviPro ND C131, SPC_cleared 2 Concurrent infections for example with _Mycoplasma, E. coli, Aspergillus _or _Ornithobacterium _ _rhinotracheale _may cause complications_. _ 4.5 SPECIAL PRECAUTIONS FOR USE SPECIAL PRECAUTIONS FOR USE IN ANIMALS The Citiți documentul complet